Badgley, Phelps & Bell’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $28.4M | Buy |
56,200
+2,544
| +5% | +$1.2M | 1.05% | 25 |
|
|
2021
Q1 | $24.5M | Sell |
53,656
-2,276
| -4% | -$1.09M | 1.02% | 25 |
|
|
2020
Q4 | $26.1M | Sell |
55,932
-1,870
| -3% | -$877K | 1.13% | 21 |
|
|
2020
Q3 | $25.5M | Sell |
57,802
-1,287
| -2% | -$532K | 1.25% | 20 |
|
|
2020
Q2 | $21.4M | Sell |
59,089
-389
| -0.7% | -$130K | 1.18% | 18 |
|
|
2020
Q1 | $16.9M | Sell |
59,478
-1,191
| -2% | -$376K | 1.11% | 22 |
|
|
2019
Q4 | $19.7M | Sell |
60,669
-305
| -0.5% | -$92.5K | 1.03% | 26 |
|
|
2019
Q3 | $17.8M | Buy |
60,974
+425
| +0.7% | +$122K | 1.01% | 32 |
|
|
2019
Q2 | $17.8M | Sell |
60,549
-1,117
| -2% | -$308K | 1.04% | 31 |
|
|
2019
Q1 | $16.9M | Sell |
61,666
-13,616
| -18% | -$3.39M | 1.02% | 31 |
|
|
2018
Q4 | $16.8M | Buy |
75,282
+904
| +1% | +$212K | 1.22% | 19 |
|
|
2018
Q3 | $18.2M | Sell |
74,378
-1,201
| -2% | -$276K | 1.11% | 20 |
|
|
2018
Q2 | $15.7M | Sell |
75,579
-270
| -0.4% | -$57.3K | 1.02% | 24 |
|
|
2018
Q1 | $15.7M | Sell |
75,849
-771
| -1% | -$162K | 1.04% | 20 |
|
|
2017
Q4 | $14.5M | Sell |
76,620
-1,797
| -2% | -$344K | 1% | 22 |
|
|
2017
Q3 | $14.8M | Sell |
78,417
-1,243
| -2% | -$225K | 1.1% | 18 |
|
|
2017
Q2 | $13.9M | Sell |
79,660
-1,212
| -1% | -$204K | 1.08% | 18 |
|
|
2017
Q1 | $12.4M | Sell |
80,872
-2,053
| -2% | -$314K | 1% | 23 |
|
|
2016
Q4 | $11.7M | Sell |
82,925
-1,780
| -2% | -$262K | 1.02% | 27 |
|
|
2016
Q3 | $13.5M | Sell |
84,705
-1,119
| -1% | -$172K | 1.19% | 17 |
|
|
2016
Q2 | $12.7M | Sell |
85,824
-813
| -0.9% | -$120K | 1.16% | 21 |
|
|
2016
Q1 | $12.3M | Sell |
86,637
-502
| -0.6% | -$67.3K | 1.15% | 22 |
|
|
2015
Q4 | $12.4M | Sell |
87,139
-1,916
| -2% | -$256K | 1.22% | 18 |
|
|
2015
Q3 | $10.9M | Sell |
89,055
-3,552
| -4% | -$463K | 1.13% | 24 |
|
|
2015
Q2 | $12M | Sell |
92,607
-1,118
| -1% | -$146K | 1.17% | 20 |
|
|
2015
Q1 | $12.6M | Sell |
93,725
-1,885
| -2% | -$243K | 1.24% | 18 |
|
|
2014
Q4 | $12M | Sell |
95,610
-2,194
| -2% | -$267K | 1.17% | 18 |
|
|
2014
Q3 | $11.9M | Sell |
97,804
-664
| -0.7% | -$80.7K | 1.18% | 22 |
|
|
2014
Q2 | $11.6M | Sell |
98,468
-1,888
| -2% | -$222K | 1.16% | 25 |
|
|
2014
Q1 | $12.1M | Buy |
100,356
+623
| +0.6% | +$74.1K | 1.24% | 19 |
|
|
2013
Q4 | $11.1M | Buy |
99,733
+830
| +0.8% | +$82.5K | 1.17% | 24 |
|
|
2013
Q3 | $9.11M | Sell |
98,903
-366
| -0.4% | -$33.1K | 1.02% | 32 |
|
|
2013
Q2 | $8.4M | Buy |
+99,269
| New | +$8.26M | 0.99% | 31 |
|
Other funds holding TMO
Badgley, Phelps & Bell's TMO Position: Q2 2021 in Review
Badgley, Phelps & Bell increased its Thermo Fisher Scientific (TMO) stake by 4.7% in Q2 2021, buying an estimated $1.2M and bringing the position to 56,200 shares worth $28.4M. The position accounts for 1.05% of the portfolio, ranked #25.
Badgley, Phelps & Bell first reported a position in TMO in Q2 2013 and has held it in 33 quarters since. 2,075 funds tracked by Wall St. Rank hold TMO as of Q2 2021.
- Badgley, Phelps & Bell held 56,200 shares of Thermo Fisher Scientific worth $28.4M as of Q2 2021.
- Badgley, Phelps & Bell bought 2,544 Thermo Fisher Scientific shares in Q2 2021, an estimated $1.2M.
- Thermo Fisher Scientific made up 1.05% of Badgley, Phelps & Bell's portfolio in Q2 2021, its #25 holding.
- Badgley, Phelps & Bell first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 33 quarters since.
- 2,075 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2021.
Based on Badgley, Phelps & Bell's 13F filing for Q2 2021, filed 28 Jul 2021.